DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439,991 | +4.2% | 5,804 | +0.8% | 0.14% | +6.6% |
| Q2 2023 | $1,382,232 | -4.5% | 5,759 | +0.3% | 0.14% | -10.5% |
| Q1 2023 | $1,447,787 | -5.0% | 5,744 | +0.0% | 0.15% | -11.1% |
| Q4 2022 | $1,524,110 | +1.3% | 5,742 | -1.4% | 0.17% | -21.6% |
| Q3 2022 | $1,505,000 | -1.6% | 5,826 | -3.5% | 0.22% | +6.3% |
| Q2 2022 | $1,530,000 | -14.0% | 6,036 | -0.5% | 0.20% | -4.2% |
| Q1 2022 | $1,779,000 | -10.2% | 6,064 | +0.8% | 0.21% | -18.0% |
| Q4 2021 | $1,980,000 | +9.3% | 6,018 | +1.1% | 0.26% | -5.1% |
| Q3 2021 | $1,812,000 | -9.6% | 5,952 | -20.3% | 0.28% | -18.2% |
| Q2 2021 | $2,004,000 | +28.6% | 7,468 | +7.9% | 0.34% | -5.4% |
| Q1 2021 | $1,558,000 | +2.5% | 6,922 | +1.1% | 0.36% | -11.2% |
| Q4 2020 | $1,520,000 | +13.5% | 6,844 | +10.1% | 0.40% | -3.6% |
| Q3 2020 | $1,339,000 | +19.1% | 6,218 | -2.2% | 0.42% | +4.0% |
| Q2 2020 | $1,124,000 | +6.1% | 6,359 | -16.9% | 0.40% | -11.7% |
| Q1 2020 | $1,059,000 | -11.7% | 7,650 | -2.0% | 0.45% | +9.4% |
| Q4 2019 | $1,199,000 | +10.4% | 7,809 | -0.9% | 0.41% | +5.6% |
| Q3 2019 | $1,086,000 | +219.4% | 7,883 | +231.2% | 0.39% | +73.8% |
| Q2 2019 | $340,000 | +8.3% | 2,380 | 0.0% | 0.22% | +4.7% |
| Q1 2019 | $314,000 | +28.2% | 2,380 | 0.0% | 0.22% | +9.7% |
| Q4 2018 | $245,000 | -5.4% | 2,380 | 0.0% | 0.20% | +5.4% |
| Q3 2018 | $259,000 | +10.2% | 2,380 | 0.0% | 0.19% | -5.1% |
| Q2 2018 | $235,000 | – | 2,380 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |